Financial presentations
Redeye interview with AroCell CEO, Anders Hultman 2021-09-02
Commenting Interim Report Q2 2021
Interview with Anders Hulman and Peter Löwendahl, 2021-08-12
Only in swedish
Growth Day 2021 - AROCELLS CEO ANDERS HULTMAN
Only in swedish
REDEYE INTERVJU WITH AROCELLS CEO ANDERS HULTMAN 2021-05-19
Only in swedish
REDEYE INTERVJU WITH AROCELLS CEO ANDERS HULTMAN 2021-05-10
Only in swedish
Redeye interview with AroCell CEO, Anders Hultman 2021-02-19
Commenting Interim Report Q4 2020
CEO Anders Hultman Commenting FDA Delay due to Covid-19
Redeye interview 2021-01-20
Commenting CEO transition, interview by Redeye
2021-01-12
Life Science Day 2020
REDEYE INTERVIEWING AROCELL’S CEO, MICHAEL BROBJER 2020-11-23
Commenting Interim Report Q3 2020
Redeyes Diagnostic Seminar 2020
Michael Brobjer presenting, 21-10-2020
Strategy Update Live Presentation 2020-06-15
REDEYE INTERVIEWING AROCELL’S CEO MICHAEL BROBJER and CMO Cecilia Ahlin 2020-05-27
Commenting 510(k) submission to FDA
REDEYE INTERVIEWING AROCELL’S CEO, MICHAEL BROBJER 2020-05-18
Commenting Interim Report Q1 2020
AroCell Presentation at Redeye Medtech & Diagnostics 5 maj 2020
REDEYE INTERVIEWING AROCELL’S CEO, MICHAEL BROBJER 2020-02-21
Commenting Year-End Report 2019
REDEYE INTERVIEWING AROCELL’S CEO, MICHAEL BROBJER 2019-12-09
Arocell interview at Biostock Live, 3 december 2019
AroCell company presentation at BioStock Live, 3 December 2019
Anders Hultman, CFO, presenting at Stora Aktiedagen Stockholm 2019
Michael Brobjer, CEO, presents at Redeye LIFE SCIENCE DAY 2019
Michael Brobjer, CEO, presents at Redeye Investor After Work Gothenburg 2019
Michael Brobjer, CEO, presents the Q3 report 2019 plus Q&A with Redeye
Video is in Swedish.
Redeye interviewing AroCell’s CEO, Michael Brobjer
AroCell ProHearings 2019-02-22
AroCell’s CEO share his views on the company in a video interview
AroCell ProHearings 2018-02-16
Arocell tecknar licenseavtal med Roche
